Network on veterinary medicines initiated by the European Federation For Pharmaceutical Sciences

The European Federation for Pharmaceutical Sciences (EUFEPS) was founded 25 years ago by more than 20 national pharmaceutical societies and faculty members. As a pan‐European organization, it brings together pharmaceutical societies as well as academic, industrial and regulatory scientists engaged in drug research and development, drug regulation and education of professionals working in these fields. EUFEPS represents pharmaceutical sciences in Europe and is recognized as such by both the European Commission and the European Medicines Agency. EUFEPS cooperates with the European Federation of Pharmaceutical Industries and other European organizations and maintains global connections with agencies such as the US Food and Drug Administration and the American Association of Pharmaceutical Scientists. EUFEPS has established specified networks forming the basis of its activities. The creation of a Network on Veterinary Medicines is prompted by the manifold problems resulting from the use of veterinary drugs and its inherent interconnections with human medicine, environmental and public health. A long‐term goal of this initiative was to expand the spectrum of available therapeutics for use in animals, including the development of innovative delivery systems.     

Pharmacokinetics of multiple doses of transdermal flunixin meglumine in adult Holstein dairy cows

A transdermal formulation of the nonsteroidal anti‐inflammatory drug, flunixin meglumine, has been approved in the United States and Canada for single‐dose administration. Transdermal flunixin meglumine was administered to 10 adult Holstein cows in their second or third lactation at the label dose of 3.33 mg/kg every 24 hr for three total treatments. Plasma flunixin concentrations were determined using high‐pressure liquid chromatography with mass spectroscopy (HPLC ‐MS ). Pharmacokinetic analysis was completed on each individual animal with noncompartmental methods using computer software. The time to maximum drug concentration (T max) was 2.81 hr, and the maximum drug concentration was 1.08 μg/ml. The mean terminal half‐life (T½) was determined to be 5.20 hr. Clearance per fraction absorbed (Cl/F) was calculated to be 0.294 L/hr kg^?1, and volume of distribution of fraction (V z/F ) absorbed was 2.20 L/kg. The mean accumulation factor was 1.10 after three doses. This indicates changes in dosing may not be required when giving multiple doses of flunixin transdermal. Further work is required to investigate the clinical efficacy of transdermal flunixin after multiple daily doses.     

Acupuncture and traditional Chinese veterinary medicine for treatment of a mare with rectal paralysis

An 8‐year‐old Appaloosa mare with rectal paralysis due to a cosmetic ethanol ‘tail block’ was treated with traditional Chinese veterinary medicine treatments including acupuncture and herbal medicine. Her rectal and tail tone gradually improved after the treatment. At 4 months after initial presentation, the mare was able to produce faecal piles on a regular basis, and manual evacuations were no longer needed. Significant improvement was within 30 days of beginning treatment. At 8 months, the owner indicated that the mare had normal defaecation, was able to swish the tail from side to side and lift the tail to urinate, and had no evidence of straining to defaecate or colic.     

Investigation of Clinical Medicine for Treating Cows Endometritis in Baotou Area

In 4 dairy farms located in Baotou area, clinical medicine investigation and drug resistance of pathogenic bacteria were conducted, and then curative effects of different treatment methods were analyzed.Epidemic materials were collected from diary cows infected by endometritis, from which pathogenic bacteria were isolated using conventional microbiology technologies.Broth microdilution method was used to detect the sensitivity and resistance of pathogenic bacteria to antibiotics commonly used in clinic.On this basis, the sensitive drugs were used to treat mastitis or endometritis, the clinical curative effect of traditional treatment group was compared with that of therapeutic test group.The result of traditional treatment group showed 13 antibiotics were used to treat 160 cases of endometritis, florfenicol was most effective, penicillin was most ineffective.The results of therapeutic test group showed that Staphylococcus aureus, Escherichia coli and Streptococcus were the main pathogenic bacteria of endometritis, which were sensitive to gentamicin and cefalotin, etc.The results of statistical analysis showed that the curative effect of therapeutic test group was extremely significantly different from that of traditional treatment group(P<0.01).Sensitive drugs screened by drug sensitive test could be used to target therapy, and obtain satisfied curative effect.Moreover, this approach could avoid antibiotic abuse.     

1株鸭源非O1/O139群霍乱弧菌的分离鉴定与致病性分析

为探明引起贵州省某鸭场雏鸭发病的病原及其致病性和耐药情况，本研究对该鸭场送的疑似细菌感染病鸭进行剖检，取鼻黏膜、心脏和肝脏等组织器官接种于培养基中进行细菌分离鉴定，通过对分离菌进行药敏试验、动物回归试验和毒力基因检测研究其耐药情况和致病性。结果显示，分离菌在血琼脂培养基上生长16 h后呈现为边缘整齐、有光泽的乳白色菌落，伴有β-溶血现象，经革兰氏染色后在生物显微镜下呈两端钝圆、弧状、排列无规则的革兰氏阴性短小杆菌，与霍乱弧菌相符；16S rDNA基因序列同源性及系统进化树显示，该分离菌与霍乱弧菌同源性高达99.6%~99.7%聚为一支；药敏试验结果显示，分离菌对大部分药物都表现为耐药，其中对氨苄西林、克林霉素、复方新诺明、苯唑西林和克林霉素等抗菌药耐药性较强，对头孢哌酮和头孢曲松敏感；动物回归试验显示，分离菌可导致试验组雏鸭5 d内全部发病死亡，表明该分离菌对雏鸭具有较强的致病性；毒力基因PCR检测结果显示，检测的霍乱弧菌相关毒力基因hlyA、ompW和chxA为阳性，而检测的O1群rfb、O139群rfb、tcpA及ctxA基因为阴性，表明本次分离的霍乱弧菌携带有致病基因，但不属于O1和O139血清群。结果表明，该鸭场雏鸭发病的疫情病原为非O1/O139血清群霍乱弧菌，该菌致病性强且对多种抗菌药物耐药。本试验结果为贵州省鸭霍乱弧菌病的防控提供了参考依据。     

大肠杆菌多重耐药株与敏感株蛋白质组差异分析

【目的】研究临床分离的大肠杆菌多重耐药株(R)与大肠杆菌标准株ATCC 25922(S)蛋白质差异表达情况,为进一步研究大肠杆菌耐药机理奠定基础。【方法】采用串联质谱标签(tandem mass tag,TMT)法结合平行反应监测(parallel reaction monitoring,PRM)技术,对大肠杆菌R和S株的全菌体蛋白进行定量蛋白质组学研究,筛选大肠杆菌多重耐药株(S)与敏感株(R)之间的差异表达蛋白,并对其生物信息学进行分析。【结果】共筛选出300个差异表达蛋白(Fold change≥1.3,P0.05),其中上调167个,下调133个,涉及的耐药相关通路主要包括细菌趋药性、ABC转运蛋白、β-内酰胺抗性等;PRM成功定量到13个差异蛋白,且PRM验证结果与TMT定量结果一致。【结论】筛选出多个与大肠杆菌耐药性相关的差异表达蛋白和通路。     

林麝肺源ST1249型铜绿假单胞菌的分离鉴定及其全基因组序列分析

【目的】对分离自林麝化脓肺脏的1株疑似铜绿假单胞菌(PA)进行鉴定,并分析其致病和耐药机制,为林麝PA感染化脓性疾病的防控奠定基础。【方法】将病原菌分离纯化后,依次进行生化试验、16S rRNA序列分析、药敏试验和小鼠致病性试验,并通过全基因组测序,对分离菌株进行群体进化和物种分型分析以及基因功能注释。【结果】分离自林麝化脓肺脏的1株疑似铜绿假单胞菌经鉴定与PA相符,命名为FMDP001。药敏试验显示其对阿莫西林、头孢曲松、氨曲南、多粘菌素B和林可霉素耐药;对小鼠半数致死量为9.4×10~5 CFU/mL。全基因组序列分析显示该菌基因组大小为6 955 100 bp,序列类型为ST1249,与B136-33株同源性最高,且两菌株基因组平均核苷酸一致性(ANI)值达98.93%;全基因组中共有357个序列编码FMDP001与致病性相关的基因,根据功能分为黏附、铁摄取、胞外毒性蛋白和调控系统;84个序列编码耐药基因,其中多药耐药外排泵为主要成分。【结论】从林麝化脓肺脏中分离到1株致病性较强的PA,并获得ST1249型林麝源PA的全基因组序列,序列显示该菌携带大量药物外排泵及生物膜形成相关基因,决定其具有多重耐药特性,哌拉西林等可作为该类型PA感染的临床用药。     

山西特色资源植物数据库的建立

本文通过搜集山西省资源植物的基本资料和查阅相关文献,结合植物的经济用途和传统植物分类方法,将山西省资源植物分为十五类。利用现代信息技术,创建了山西资源植物数据库,实现了山西资源植物的信息共享,为今后更合理地开发利用资源植物提供科学依据。     

江苏省推行兽药GSP的体会与思考

回顾总结了江苏省兽药GSP试点工作的主要做法,阐述了制定江苏省关于实施<兽药经营质量管理规范>细则的几点考虑,以及贯彻实施<兽药经营质量管理规范>的基本思路,供参考借鉴.     

治疗仔猪黄白痢中兽药临床处方筛选

为了筛选出治疗仔猪黄白痢的最佳中药处方，确定其合理用药剂量和适用范围，试验将478头确诊为黄白痢的哺乳仔猪随机分为6组，分别用3种预选处方（处方一、处方二和处方三）、氧氟沙星、诺氟沙星、氧氟沙星与诺氟沙星联合用药进行治疗，比较预选处方与对照药物对仔猪黄白痢的治疗效果，筛选最佳的中药处方；并对每种中药处方按照低、中、高3种剂量进行用药，确定预选处方的合理用药剂量；按照发病特点进行用药。探讨预选处方对不同病症的适用性。结果表明：预选处方对仔猪黄白痢的治疗效果优于对照药物，且复发率显著低于后者；3种中药处方中，处方一的疗效最好，治愈率为82．9％，总有效率可迭84．7％，显著高于其他处方；处方一中剂量组的疗效最好，治愈率为88．9％，总有效率可达91．1％，显著高于其他剂量组，而且治愈后无复发现象。